Revenue: As of FY2025, the actual value is USD 7.401 B, beating the estimate of USD 7.347 B.EPS: As of FY2025, the actual value is USD 6.4, missing the estimate of USD 6.4075.EBIT: As of FY2025, the actual value is USD 1.986 B.<h4>Consolidated Financial Performance</h4><ul><li>Net Income: AMETEK, Inc. reported net income of $1,480.1 million in 2025, an increase of 7.6% from $1,376.1 million in 2024.</li><li>Orders: Orders totaled $7,579.4 million in 2025, an increase of 11.3% from $6,810.3 million in 2024, driven by a 4% increase from acquisitions, a 4% organic order increase, and a 3% favorable effect of foreign currency translation.</li><li>Backlog: The company’s backlog stood at $3,581.5 million at December 31, 2025, a 5.2% increase from $3,403.2 million at December 31, 2024.</li><li>Operating Cash Flow: Operating cash flow was $1,801.8 million in 2025, a decrease of 1.5% from $1,828.8 million in 2024, primarily due to higher working capital investments, partially offset by higher net income.</li><li>Free Cash Flow: Free cash flow was $1,671.6 million in 2025, compared with $1,701.7 million in 2024.</li><li>EBITDA: EBITDA was $2,296.9 million in 2025, compared with $2,151.7 million in 2024.</li><li>Acquisition Spending: AMETEK, Inc. spent $933.2 million in cash (net of cash acquired) in 2025 to purchase Kern Microtechnik and FARO Technologies.</li><li>Share Repurchases: The company repurchased approximately 2.3 million shares for $443.0 million in 2025, an increase from approximately 1.2 million shares for $212.0 million in 2024.</li><li>Sales from New Products: Approximately 27% of sales in 2025 were from products introduced in the past three years.</li><li>Cost of Sales: Cost of sales was $4,733.7 million or 64.0% of net sales in 2025, compared with $4,464.7 million or 64.3% of net sales in 2024.</li><li>Selling, General and Administrative Expenses: These expenses were $757.1 million or 10.2% of net sales in 2025, an 8.6% increase from $696.9 million or 10.0% of net sales in 2024.</li><li>Consolidated Operating Income: Consolidated operating income was $1,910.3 million or 25.8% of net sales in 2025, an increase of 7.3% from $1,779.6 million or 25.6% of net sales in 2024.</li><li>Interest Expense: Interest expense decreased by 28.1% to $81.3 million in 2025 from $113.0 million in 2024.</li><li>Other Expense, Net: Other expense, net, was $30.7 million in 2025, up from $5.1 million in 2024, primarily due to $12.0 million in acquisition-related transaction costs and increased environmental spend.</li><li>Effective Tax Rate: The effective tax rate was 17.7% in 2025, compared with 17.2% in 2024.</li><li>Capital Expenditures: Capital expenditures were $130.2 million or 1.8% of net sales in 2025, compared with $127.1 million or 1.8% of net sales in 2024.</li><li>Total Debt, Net: Total debt, net, was $2,283.3 million at December 31, 2025, compared with $2,079.7 million at December 31, 2024.</li><li>Net Debt-to-Capital Ratio: The net debt-to-capital ratio was 14.7% at December 31, 2025, compared with 15.0% at December 31, 2024.</li></ul><h4>Electronic Instruments Group (EIG)</h4><ul><li>Segment Revenue: Net sales for EIG were $4,919.1 million in 2025, an increase of 5.6% from $4,659.9 million in 2024. This growth was attributed to a 6% increase from acquisitions and a 1% favorable foreign currency translation effect, partially offset by a 1% organic sales decrease.</li><li>Revenue by Product Category (2025): Process and Analytical Instrumentation accounted for $3,464.3 million (70% of EIG net sales), while Aerospace and Power Instrumentation contributed $1,454.8 million (30% of EIG net sales).</li><li>Operating Income: EIG’s operating income was $1,447.1 million in 2025, an increase of 1.3% from $1,428.4 million in 2024.</li><li>Operating Margins: Operating margins were 29.4% of net sales in 2025, down from 30.7% in 2024, negatively impacted by 100 basis points from dilutive acquisitions and 50 basis points from acquisition-related integration costs. Excluding these impacts, operating margins increased by 20 basis points.</li><li>International Sales: International sales constituted 52% of EIG’s net sales in 2025.</li><li>Employees: EIG had approximately 12,800 employees at December 31, 2025.</li><li>Depreciation: Depreciation expenses were $77,538 thousand in 2025, compared with $71,351 thousand in 2024.</li><li>Amortization: Amortization expenses were $186,722 thousand in 2025, compared with $173,209 thousand in 2024.</li><li>Research, Development &amp; Engineering Costs: These costs were $300,880 thousand in 2025, compared with $299,441 thousand in 2024.</li><li>Capital Expenditures: Capital expenditures for EIG were $61,569 thousand in 2025, compared with $58,859 thousand in 2024.</li></ul><h4>Electromechanical Group (EMG)</h4><ul><li>Segment Revenue: EMG’s net sales were $2,482.0 million in 2025, an increase of 8.8% from $2,281.3 million in 2024. This was driven by an 8% organic sales increase and a 1% favorable foreign currency translation effect.</li><li>Revenue by Product Category (2025): Automation and Engineered Solutions generated $1,749.7 million (70% of EMG net sales), and Aerospace Sales contributed $732.4 million (30% of EMG net sales).</li><li>Operating Income: Operating income for EMG was $578.9 million in 2025, a significant increase of 26.8% from $456.5 million in 2024.</li><li>Operating Margins: Operating margins improved to 23.3% of net sales in 2025 from 20.0% in 2024. The 2024 margins included a negative impact of 130 basis points from $29.2 million in acquisition-related integration costs (Paragon acquisition); excluding this, operating margins increased by 200 basis points.</li><li>International Sales: International sales accounted for 42% of EMG’s net sales in 2025.</li><li>Employees: EMG had approximately 9,400 employees at December 31, 2025.</li><li>Depreciation: Depreciation expenses were $61,986 thousand in 2025, compared with $58,049 thousand in 2024.</li><li>Amortization: Amortization expenses were $90,546 thousand in 2025, compared with $74,452 thousand in 2024.</li><li>Research, Development &amp; Engineering Costs: These costs were $81,879 thousand in 2025, compared with $72,434 thousand in 2024.</li><li>Capital Expenditures: Capital expenditures for EMG were $42,456 thousand in 2025, compared with $41,022 thousand in 2024.</li></ul><h4>Outlook / Guidance</h4>AMETEK, Inc. anticipates capital expenditures to be approximately 2% of net sales in 2026, with a continued focus on productivity improvements. The company estimates cash contributions of approximately $6.5 million to $8.5 million to its worldwide defined benefit pension plans in 2026. The Board of Directors approved a 10% increase in the quarterly cash dividend to $0.34 per share, effective February 12, 2026.

Ametek | 10-K: FY2025 Revenue Beats Estimate at USD 7.401 B